Company Overview - Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases [4] - The company focuses on the relationship between angiogenesis, the immune system, and tumor growth, aiming to create a robust pipeline of novel product candidates [4] - Founded in 2014 and headquartered in Boston, Massachusetts, Compass Therapeutics plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies [4] Upcoming Investor Events - Compass Therapeutics will participate in several investor events in September 2025, including: - Citi's 2025 Biopharma Back to School Conference on September 2, 2025, in Boston, MA [2] - Cantor Global Healthcare Conference on September 3, 2025, in New York, NY, at 2:10 PM ET [2] - H.C. Wainwright 27 Annual Global Investment Conference on September 8, 2025, in New York, NY, at 11 AM ET [2] - Morgan Stanley 23 Annual Global Healthcare Conference on September 9, 2025, in New York, NY, at 5:35 PM ET [3] - Webcast links for the Cantor and H.C. Wainwright conferences are provided for investor access [2][3]